These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 406909)

  • 1. Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.
    Majerus PW; Stanford N
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):15S-18S. PubMed ID: 406909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of interaction of acetylsalicylic acid and indomethacin with endoperoxide prostaglandin synthetase].
    Muratov VK; Igumnova ND; Basevich VV; Churiukanov VV; Mevkh AT
    Farmakol Toksikol; 1983; 46(5):44-8. PubMed ID: 6414841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation of prostaglandin synthase by aspirin.
    Roth GJ; Stanford N; Majerus PW
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3073-6. PubMed ID: 810797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2-component inhibition of prostaglandin H synthetase by nonsteroidal anti-inflammatory preparations].
    Muratov VK; Mevkh AT; Igumnova ND; Churiukanov VV; Varfolomeev SD
    Farmakol Toksikol; 1987; 50(1):46-9. PubMed ID: 3104082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostaglandin synthase by pirprofen. Studies with sheep seminal vesicle enzyme.
    Ku EC; Wasvary JM
    Biochim Biophys Acta; 1975 Apr; 384(2):360-8. PubMed ID: 804924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostaglandin synthetase by tolmetin (Tolectin, McN-2559), a new non-steroidal anti-inflammatory agent.
    Taylor RJ; Salata JJ
    Biochem Pharmacol; 1976 Nov; 25(22):2479-84. PubMed ID: 825128
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations.
    Dembinska-Kieĉ A; Zmuda A; Krupinska J
    Adv Prostaglandin Thromboxane Res; 1976; 1():99-103. PubMed ID: 826149
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostaglandin synthetase by anti-tumour agents.
    Tisdale MJ
    Chem Biol Interact; 1977 Jul; 18(1):91-100. PubMed ID: 408018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of substrate concentration on inhibition of prostaglandin synthetase of bull seminal vesicles by anti-inflammatory drugs and fenamic acid analogs.
    Cushman DW; Cheung HS
    Biochim Biophys Acta; 1976 Mar; 424(3):449-59. PubMed ID: 816374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.
    Roth GJ; Siok CJ
    J Biol Chem; 1978 Jun; 253(11):3782-4. PubMed ID: 418070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase.
    Ku EC; Wasvary JM; Cash WD
    Biochem Pharmacol; 1975 Mar; 24(5):641-3. PubMed ID: 804905
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiinflammatory agents and inhibition of ocular prostaglandin synthetase.
    Ku EC; Signor C; Eakins E
    Adv Prostaglandin Thromboxane Res; 1976; 2():819-23. PubMed ID: 824938
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical properties of the prostaglandin/thromboxane synthetase of human blood platelets and comparison with the synthetase of bovine seminal vesicles.
    White HL; Glassman AT
    Prostaglandins; 1976 Nov; 12(5):811-28. PubMed ID: 10602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of diflunisal.
    Hannah J; Ruyle WV; Jones H; Matzuk AR; Kelly KW; Witzel BE; Holtz WJ; Houser RW; Shen TY; Sarett LH
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):7S-13S. PubMed ID: 328036
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of diflunisal on platelet function and fecal blood loss.
    Green D; Davies RO; Holmes GI; Kohl H; Lee RB; Reynolds N; Schmid FR; Ts'ao C
    Clin Pharmacol Ther; 1981 Sep; 30(3):378-84. PubMed ID: 6974077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats.
    Hung DY; Mellick GD; Masci PP; Whitaker AN; Whitehouse MW; Roberts MS
    J Lab Clin Med; 1998 Dec; 132(6):469-77. PubMed ID: 9851736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mode of action and biochemical properties of anti-inflammatory drugs-II.
    Saeed SA; Cuthbert J
    Prostaglandins; 1977 Mar; 13(3):565-75. PubMed ID: 403575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does non-acetylated salicylate inhibit thromboxane biosynthesis in human platelets?
    Danesh BJ; McLaren M; Russell RI; Lowe GD; Forbes CD
    Scott Med J; 1988 Aug; 33(4):315-6. PubMed ID: 3187504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.